169 results on '"Kollen, Wouter"'
Search Results
2. Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer
3. Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
4. Improving Handoff by Deliberate Cognitive Processing: Results from a Randomized Controlled Experimental Study
5. Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia
6. CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation
7. Model-Based Dosing of Anti-Thymocyte Globulin in Pediatric Allogeneic Hematopoietic Cell Transplantation Improves Survival Chances: Updated Results from the Single Arm Phase II Parachute-Trial Combined with Real-World Data
8. Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients
9. Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients
10. The Effect of Cidofovir on Adenovirus Plasma DNA Levels in Stem Cell Transplantation Recipients without T Cell Reconstitution
11. Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation
12. A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
13. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol
14. Maagsonde in situ
15. Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
16. Encouraging Outcomes after Unrelated Cord Blood Grafts for Post-Transplant Relapse in Pediatric Patients
17. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations
18. Improving Handoff by Deliberate Cognitive Processing: Results from a Randomized Controlled Experimental Study
19. CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation
20. Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood
21. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants
22. Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia Is an Effective, Low Toxic TBI-Free Conditioning Regimen
23. Atypical varicella zoster infection associated with hemophagocytic lymphohistiocytosis
24. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants
25. 559 - Encouraging Outcomes after Unrelated Cord Blood Grafts for Post-Transplant Relapse in Pediatric Patients
26. Enhanced Efficiency of Lactosylated Poly-l-Lysine-Mediated Gene Transfer into Cystic Fibrosis Airway Epithelial Cells
27. Glycosylated Polylysines*: Nonviral Vectors for Gene Transfer Into Cystic Fibrosis Airway Epithelial Cells
28. Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia : A randomized multicenter study of the Dutch Childhood Oncology Group
29. Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group
30. Targeted Deep Sequencing of GATA1 more Sensitively Identifies Transient Myeloproliferative Disorder in Neonates with Down Syndrome
31. Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group
32. Recurrent Translocation t(10;17)(p15;q21) in Minimally Differentiated Acute Myeloid Leukemia Results in ZMYND11/MBTD1 Fusion
33. CD4+T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation
34. Sensitive GATA1mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia
35. Haematopoietic Cell Transplant (HCT) in Pediatric Acute Myeloid Leukemia (AML) after Similar Upfront Therapy with AML-Nopho; a Comparison of Conditioning Regimens
36. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations
37. CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons
38. Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
39. Combining Clofarabine and Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxicity TBI-Free Conditioning Regimen
40. Population Pharmacokinetics of Erwinia Asparaginase in Pediatric ALL Patients
41. Recurrent translocation t(10;17)(p15;q21) in minimally differentiated acute myeloid leukemia results in ZMYND11/MBTD1 fusion
42. Combining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia: An Effective, Low Toxic TBI-Free Conditioning Regimen
43. 110 - Haematopoietic Cell Transplant (HCT) in Pediatric Acute Myeloid Leukemia (AML) after Similar Upfront Therapy with AML-Nopho; a Comparison of Conditioning Regimens
44. A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia
45. The Effectiveness Of Cidofovir In Disseminated Adenovirus Infections After Pediatric HSCT Is Closely Related To Lymphocyte Reconstitution
46. Bone Mineral Density At Diagnosis Determines Fracture Rate in Children Treated According to the DCOG-ALL9 Protocol
47. A Panel of Artificial APCs Expressing Prevalent HLA Alleles Permits Generation of Cytotoxic T Cells Specific for Both Dominant and Subdominant Viral Epitopes for Adoptive Therapy
48. A Panel of Artificial Antigen-Presenting Cells (AAPC) Expressing Prevalent HLA Alleles Permits Generation of Cytotoxic T Cells Specific for Both Subdominant and Dominant Viral Epitopes for Adoptive Therapy.
49. A Panel of Artificial Antigen Presenting Cells (AAPC) Permits Immediate Sensitization and Rapid Generation of Virus-Specific T-Cells of Desired HLA Restriction for Adoptive Immunotherapy.
50. Artificial Antigen-Presenting Cells Permit Selective In Vitro Generation of CMV-Specific T-Cells of Desired HLA Allelic Restriction for Adoptive Immunotherapy in Recipients of HLA Disparate Allografts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.